Skip to content

Stereotaxis STXS Return on equity

Return on equity at other companies

Abbott logo
AbbottABT
12.4%-18.4pp
Boston Scientific logo
Boston ScientificBSX
14.8%+5.2pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp
ITG
Integer HoldingsITGR
8.6%+3.7pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9.1%0.0pp
iRadimed logo
iRadimedIRMD
25%+1.2pp

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Calculated from Stereotaxis’s reported figures.

Based on trailing twelve months.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's return on equity?
Stereotaxis (STXS) reported return on equity of -251.5% in Q1 2026.
How has Stereotaxis's return on equity changed year-over-year?
Stereotaxis's return on equity increased by 13.5% year-over-year, from -290.7% to -251.5%.
What is the long-term trend for Stereotaxis's return on equity?
Over 5 years (2020 to 2025), Stereotaxis's return on equity has grown at a 57.0% compound annual growth rate (CAGR), from -23.2% to -221.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.